2,098
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Cobalt-60 is a logical, economical and comparable alternative to Ir-192: analysis and institutional experience from western India

(Junior Resident) , , MD(Radiation Oncology) (Assistant Professor) , , MD(Radiation Oncology) (Senior Resident) , , DipRadiationPhysics (Senior Physicist) , , MSc(Physics) (Medical Physicist) , , MD(Medicine) (Medical Officer) , (Junior Resident) & (Junior Resident) show all
Pages 60-63 | Received 23 Dec 2014, Accepted 18 Mar 2015, Published online: 24 Aug 2015

References

  • Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12): 2893–2917.
  • Sankaranarayanan R, Thara S, Esmy PO, Basu P. Cervical cancer: screening and therapeutic perspectives. Med Princ Pract. 2008;17(5): 351–364.
  • Viswanathan AN, Beriwal S, De Los Santos JF, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy. 2012;11(1): 47–52.
  • Eifel P. Patterns of radiotherapy practice for patients treated for intact cervical cancer in 2005-2007: a QRRO study. Int J Radiat Biol Phys. 2010;78: S119.
  • Tod M, Meredith WJ. Treatment of cancer of the cervix uteri, a revised Manchester method. Br J Radiol. 1953;26(305): 252–257.
  • Jain Vandana S, Singh Kailash K, et al. Radical radiotherapy treatment (EBRT + HDR-ICRT) of carcinoma of the uterine cervix: outcome in patients treated at a rural center in India. J Cancer Res Ther. 2007;3(4): 211–217.
  • Palmer A, Mzenda B, Hatman O, Hosseini-Ashrafi M. The physics, economics and clinical use of Co-60 for high dose rate brachytherapy. Cardiff: Institute of Physics and Engineering in Medicine; 2010.
  • Strohmaier S, Zwierzchowski G. Comparison of Co-60 and Ir-192 sources in HDR brachytherapy. J Contemp Brachytherapy. 2011;3(4): 199–208.
  • Andrassy M, Niatsetski Y. Co-60 versus Ir-192 in HDR brachytherapy: scientific and technological comparison. Rev Fis Med. 2012;13(2): 125–130.
  • International Commission on Radiation Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynaecology. Bethesda: ICRU, 1985.
  • Jamema SV, Saju S, Mahantshetty U, et al. Dosimetric evaluation of rectum and bladder using image-based CT planning and orthogonal radiographs with ICRU 38 recommendations in intracavitary brachytherapy. J Med Phys. 2008;33(1): 3–8.
  • Datta NR, Srivastava A, Maria Das KJ, et al. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-basedintracavitarybrachytherapyincervical cancer. Brachytherapy. 2006;5(4): 223–229.
  • Eich HT, Haverkamp U, Micke O, et al. Dosimetric analysis at ICRU referencepointsinHDR-brachytherapy of cervical carcinoma. Rontgenpraxis. 2000;53(2): 62–66.
  • Bahreyni Toossi MT, Ghorbani M, Makhdoumi Y, et al. A retrospective analysis of rectal and bladder dose for gynecological brachytherapy treatments with GZP6 HDR after loading system. Rep Pract Oncol Radiother. 2012;17(6): 352–357.